تفاعل #943565

معادلة التفاعل

sodium hydride

4-[4-(4-Trifluoromethoxyphenoxy)piperidin-1-yl]phenol

(R)-2-bromo-4-nitro-1-(2-methyl-2-oxiranylmethyl)imidazole

→

(R)-2-methyl-6-nitro-2-{4-[4-(4-trifluoromethoxyphenoxy)piperidin-1-yl]phenoxymethyl}-2,3-dihydroimidazo[2,1-b]oxazole

المردود 33.0%

المذيبات

N,N′-dimethylformamide

N,N′-dimethylformamide

ظروف التفاعل

المعالجة

1. 1
   درجة الحرارةwhile cooling on ice
2. 2
   درجة الحرارةThe mixture was cooled on ice
3. 3
   أخرىTo the solution, a solution prepared
4. 4
   workup.ADDITIONwas added
5. 5
   workup.STIRRINGby stirring at 70-75° C. for 20 minutes
6. 6
   أخرىto return to room temperature
7. 7
   استخلاصthe resultant solution was extracted with methylene chloride (50 ml) three times
8. 8
   غسيلwashed with water 3 times
9. 9
   تجفيفdried over magnesium sulfate
10. 10
    ترشيحAfter filtration
11. 11
    تركيزthe filtrate was concentrated
12. 12
    أخرىthe residue was purified by silica gel column chromatography (methylene chloride/ethyl acetate=3/1)
13. 13
    أخرىRecrystallization from ethyl acetate/isopropyl ether

الإجراء التجريبي

4-[4-(4-Trifluoromethoxyphenoxy)piperidin-1-yl]phenol (693 mg, 1.96 mmol) was dissolved in N,N′-dimethylformamide (3 ml), and sodium hydride (86 mg, 2.16 mmol) was added while cooling on ice followed by stirring at 70-75° C. for 20 minutes. The mixture was cooled on ice. To the solution, a solution prepared by dissolving (R)-2-bromo-4-nitro-1-(2-methyl-2-oxiranylmethyl)imidazole (720 mg, 2.75 mmol) in N,N′-dimethylformamide (3 ml) was added followed by stirring at 70-75° C. for 20 minutes. The reaction mixture was allowed to return to room temperature, ice water (25 ml) was added, and the resultant solution was extracted with methylene chloride (50 ml) three times. The organic phases were combined, washed with water 3 times, and dried over magnesium sulfate. After filtration, the filtrate was concentrated, and the residue was purified by silica gel column chromatography (methylene chloride/ethyl acetate=3/1). Recrystallization from ethyl acetate/isopropyl ether gave (R)-2-methyl-6-nitro-2-{4-[4-(4-trifluoromethoxyphenoxy)piperidin-1-yl]phenoxymethyl}-2,3-dihydroimidazo[2,1-b]oxazole (343 mg, 33%) as a light yellow powder.

المصدر